A Study Of Acoustic Vocal Analysis In Chronic Kidney Disease Undergoing Stem Cell Therapy

Overview

About this study

The purpose of this study to determine whether acoustic features in voice recordings are correlated with clinical improvement in patients with chronic kidney disease undergoing stem cell therapy, as measured by changes in serum creatinine and other clinical or patient-reported outcomes.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adults (age ≥18)
English-speaking
Ability to provide informed consent
Enrolled in Dr. Hickson’s stem cell therapy trial for chronic kidney disease

Exclusion Criteria:

Current respiratory infection
Throat or vocal condition affecting voice
Psychiatric condition impairing ability to consent

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 07/01/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Jacksonville, Fla. Mayo Clinic principal investigator Latonya Hickson, M.D.	Open for enrollment	Contact information: Quantia Wilkes M.S. (904) 953-3636 wilkes.quantia@mayo.edu

Mayo Clinic Location

Status

Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Latonya Hickson, M.D.

Open for enrollment

Contact information:

Quantia Wilkes M.S.

(904) 953-3636

wilkes.quantia@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials